Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
8.5%
1w
16.9%
1m
24.6%
3m
36.8%
6m
49.9%
1y
65.3%
5y
37.2%
all
31.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 5.9 8.5%
5.9
12.5
Company Overview

Sales
64.4 Cr
Growth: -16.8%
Profit after Tax
-44.2 Cr
Growth: -0.4%
Micro Cap
29.6 Cr
P/S: 0.5x
Industry P/S: 2.1x
Fundamentals

Sales (Cr) ₹ 64.4
Growth -16.8%
EBITDA -2.9%
P/S 0.5x
Dividend 0.0%
P/E -0.7x
Book Value ₹ 8.94
PEG Ratio 0.0x
ROE -80.2%
P/B 0.7x
Shareholding Pattern

Institutions
Promoters
Omkar Pravin Herlekar
64.47 %
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (19)
Followers (3)